|
?:authorAffiliation
|
-
[\'Medical Sciences Institute, Versiti, Milwaukee, Wisconsin, USA.\', \'Department of Research, AABB, Bethesda, Maryland, USA.\', \'Innovative Blood Resources, Division of New York Blood Center, St. Paul, Minnesota, USA.\', \'Department of Pathology and Laboratory Medicine, The University of Vermont Health Network, Burlington, Vermont, USA.\', \'New York Blood Center, New York, New York, USA.\', \'American Red Cross Blood Services, Southern California Region, Pomona, California, USA.\', \'American Red Cross Biomedical Services, Washington, District of Columbia, USA.\', \'Department of Pathology and Laboratory Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California, USA.\', \'Plasma Protein Therapeutics Association, Annapolis, Maryland, USA.\', \'Scientific, Medical, Technical Direction, OneBlood, Orlando, Florida, USA.\', \'Division of Transfusion Medicine, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.\', \'Vitalant, Scottsdale, Arizona, USA.\', \'Canadian Blood Services, Ottawa, Ontario, Canada.\']
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}